Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 834 Records) |
Query Trace: IDH1[original query] |
---|
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH -mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. medRxiv : the preprint server for health sciences 2023 9 . Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambind |
Genetic Polymorphism Study of IDH 1/2 and TET2 Genes in Acute Myeloid leukemia Patients. Asian Pacific journal of cancer prevention : APJCP 2023 9 24 (9): 3169-3182. Manal Atef, Nevine Fawzy Shafik, Nagwa H A Hassan, Rasha Mahmoud Allam, Yomna Mohamed El-Meligui, Hisham Abdelaz |
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Tin-Yun Tang, Federico Nichetti, Benjamin Kaplan, Sara Lonardi, Filippo Pietrantonio, Lisa Salvatore, Caterina Vivaldi, Lorenza Rimassa, Filippo de Braud, Mario Domenico Rizzato, Dean Pavlick, Randy Chu, Anaemy Danner De Armas, Radwa Sharaf, Ethan Sokol, Jordi Rodon Ahnert, Jeffrey S Ross, Milind Javle, Monica Nig |
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience. BMC cancer 2023 9 23 (1): 907. Elisabetta Setola, S Benini, A Righi, G Gamberi, E Carretta, C Ferrari, S Avnet, E Palmerini, G Magagnoli, M Gambarotti, P L Lollini, M Cesari, S Cocchi, A Paioli, A Longhi, K Scotlandi, M A Laginestra, D M Donati, N Baldini, T Ibrah |
Clinico-genomic profiling of conventional and dedifferentiated chondrosarcomas reveals TP53 mutation to be associated with worse outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Ryan A Denu, Richard K Yang, Alexander J Lazar, Shalin S Patel, Valerae O Lewis, Jason Roszik, J Andrew Livingston, Wei-Lien Wang, Kenna R Shaw, Ravin Ratan, Maria A Zarzour, Justin Bird, Shaan M Raza, Kadir C Akdemir, Jordi Rodon Ahnert, Vivek Subbiah, Shreyaskumar Patel, Anthony P Conl |
Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-oncology 2023 9 . Steven Tobochnik, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo L |
Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Takashi Ito, Takamichi Ishii, Haruhiko Takeda, Shinji Sumiyoshi, Katsuhiro Tomofuji, Satoshi Wakama, Kenta Makino, Hiroshi Horie, Ken Kumagai, Atsushi Takai, Elena Yukie Uebayashi, Satoshi Ogiso, Ken Fukumitsu, Hironori Haga, Hiroshi Seno, Etsuro Hata |
Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences 2023 8 . Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourig |
Overexpression of ZEB1 and YAP1 is related to poor prognosis in patients with gliomas with different IDH1 status. International journal of clinical and experimental pathology 2023 8 16 (7): 138-149. Na Miao, Zhi-Qiang Wang, Ning Zhang, Zhi-Ping Ma, Li-Ping Su, Yang-Yang Zhai, Yan-Ran Hu, Wei Sang, Wei Zha |
Platinum Sensitivity in IDH1/2 mutated Intrahepatic Cholangiocarcinoma: Not all "BRCAness" is Created Equal. Cancer investigation 2023 7 1-11. Deborah Blythe Doroshow, Wei Wei, Meenakshi Mehrotra, Daniella Sia, Joseph Paul Eder, Ranjit Bindra, Jane Houldsworth, Patricia LoRusso, Zenta Walth |
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. European journal of haematology 2023 7 . Valentina Giudice, Bianca Serio, Santa Errichiello, Idalucia Ferrara, Alessandra Galdiero, Angela Bertolini, Roberta Visconti, Danilo De Novellis, Roberto Guariglia, Serena Luponio, Denise Morini, Anna Maria Della Corte, Anna Maria Sessa, Francesco Verdesca, Maddalena Langella, Barbara Izzo, Carmine Selle |
The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. PloS one 2023 7 18 (7): e0289014. Sohaib M Al-Khatib, Obada Ababneh, Hassann Abushukair, Nour Abdo, Laith N Al-Eit |
Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia. American journal of clinical pathology 2023 7 . Joshua Tatarian, Natalie Tupper Bs, Peng Li, Julie Feusier, Maryam Abdo, Stephen Hyter, Patrick R Gonzales, Da Zhang, Janet Woodroof, Sarah Kelting, Andrew K Godwin, Wei C |
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience. Therapeutic advances in medical oncology 2023 7 15 17588359231171574. Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardi |
Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis. Translational cancer research 2023 7 12 (6): 1552-1564. Lifang Li, Jingxiong Ruan, Ning Zhang, Jia Dai, Xin Xu, Xudong Tian, Jian |
[Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 12 44 (10): 845-850. L L Wang, S N Ch |
Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
Diffusion along the perivascular space as a potential biomarker for glioma grading and isocitrate dehydrogenase 1 mutation status prediction. Quantitative imaging in medicine and surgery 2023 12 13 (12): 8259-8273. Hongquan Zhu, Yan Xie, Li Li, Yufei Liu, Shihui Li, Nanxi Shen, Jiaxuan Zhang, Su Yan, Dong Liu, Yuanhao Li, Wenzhen Z |
Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia. Hematology (Amsterdam, Netherlands) 2023 12 29 (1): 2293512. Jingying Cui, Xuexing Chen, Chunfang Li, Qiong Yan, Guolin Yu |
Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 51-55. Betul Capar Gorali, Seda Gulec Y?lmaz, Fatma Tuba Akdeniz, Rukset Attar, Turgay ?sb |
Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience. Scientific reports 2023 11 13 (1): 20101. Carmen Molica, Alessio Gili, Carlotta Nardelli, Tiziana Pierini, Silvia Arniani, Donatella Beacci, Elena Mavridou, Martina Mandarano, Rodolfo Corinaldesi, Giulio Metro, Paolo Gorello, Paolo Giovenali, Nunzia Cenci, Corrado Castrioto, Marco Lupattelli, Fausto Roila, Cristina Mecucci, Roberta La Star |
Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis. Cancer immunology, immunotherapy : CII 2023 10 . Jiashuo Chao, Shanshan Wang, Hao Wang, Nan Zhang, Yunchao Wang, Xu Yang, Chengpei Zhu, Cong Ning, Xinmu Zhang, Jingnan Xue, Longhao Zhang, Mingjian Piao, Mingming Wang, Xiaobo Yang, Ling Lu, Haitao Zh |
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling. Targeted oncology 2024 4 . Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Takeda, Takuro Mizukami, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunaka |
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2. JCO precision oncology 2024 4 8 e2300407. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases. Acta neuropathologica communications 2024 4 12 (1): 57. Yuji Kibe, Fumiharu Ohka, Kosuke Aoki, Junya Yamaguchi, Kazuya Motomura, Eiji Ito, Kazuhito Takeuchi, Yuichi Nagata, Satoshi Ito, Nobuhiko Mizutani, Yoshiki Shiba, Sachi Maeda, Tomohide Nishikawa, Hiroki Shimizu, Ryuta Sai |
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA. Experimental hematology & oncology 2024 1 13 (1): 2. Clémence Astier, Carine Ngo, Léo Colmet-Daage, Virginie Marty, Olivia Bawa, Claudio Nicotra, Maud Ngo-Camus, Antoine Italiano, Christophe Massard, Jean-Yves Scoazec, Cristina Smolenschi, Michel Ducreux, Antoine Hollebecque, Sophie Postel-Vin |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults. Pathology, research and practice 2024 1 254 155165. Ting Tang, Yihe Wang, Yang Dai, Quanlei Liu, Xiaotong Fan, Ye Cheng, Jie Tang, Xinru Xiao, Yongzhi Shan, Penghu Wei, Guoguang Zh |
GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors. Journal of neuro-oncology 2024 1 . Jotaro On, Manabu Natsumeda, Haruhiko Takahashi, Akihide Koyama, Satoshi Shibuma, Nao Shibata, Jun Watanabe, Shoji Saito, Yu Kanemaru, Yoshihiro Tsukamoto, Masayasu Okada, Ryosuke Ogura, Takeyoshi Eda, Mari Tada, Hiroshi Shimizu, Jun-Ichi Adachi, Kazuhiko Mishima, Ryo Nishikawa, Akiyoshi Kakita, Makoto Ois |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: